Neurovascular Diagnostics Inc.
Buffalo, NY
- UEI
- TJDUDJHDFL31
- CAGE
- 7NVQ3
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 303, 701 Ellicott St, Buffalo, NY 14203, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Testing a blood-based assay for detection and risk assessment of intracranial aneurysms in familial cases - project… | National Institute of Neurological Disorders and Stroke | $697,054 | |
| Development of a molecular diagnostic to identify dangerous intracranial aneurysms - project summary intracranial… | National Institute of Neurological Disorders and Stroke | $2,888,564 | |
| Molecular biomarkers of dangerous intracranial aneurysms | National Institute of Neurological Disorders and Stroke | $224,975 | |
| Sbir phase II: a blood-based test to identify patients with intracranial aneurysm | National Science Foundation | $815,820 | |
| Sbir phase i: a blood-based test to identitfy patients with intracranial aneurysm | Division of Industrial Innovation | $224,032 |
About Neurovascular Diagnostics Inc.
Neurovascular Diagnostics Inc. is a for-profit corporate entity registered to receive federal contracts and grants. Based on the background provided, it appears to be involved in developing molecular diagnostics and biomarker tests related to intracranial aneurysms.
Neurovascular Diagnostics Inc. has received multiple federal grant awards from agencies such as the National Institutes of Health (NIH) and the National Science Foundation (NSF) to develop a blood-based diagnostic test called AneuscreenTM to identify and stratify the risk of dangerous intracranial aneurysms. One project, funded by the NIH's National Institute of Neurological Disorders and Stroke, aimed to develop and validate a machine learning classifier using whole blood transcriptomes to identify high-risk aneurysm cases based on gene expression patterns. Another project, also funded by the NIH, focused on validating the genes within the aneurysm risk biomarker in a large dataset of previously-collected blood samples and standardizing the assessment of the biomarker on a clinical platform using qPCR and capillary electrophoresis. Additionally, the NSF funded a project to develop a blood-based test to identify patients with intracranial aneurysms. These projects involved developing and testing molecular diagnostics to improve the management and risk stratification of intracranial aneurysms, a potentially life-threatening condition.
Quick answers
What is Neurovascular Diagnostics Inc.'s UEI?
Neurovascular Diagnostics Inc.'s Unique Entity ID (UEI) in SAM.gov is TJDUDJHDFL31.
What is Neurovascular Diagnostics Inc.'s CAGE code?
Neurovascular Diagnostics Inc.'s CAGE code is 7NVQ3.
Where is Neurovascular Diagnostics Inc. located?
Neurovascular Diagnostics Inc.'s physical address in SAM.gov is 303, 701 Ellicott St, Buffalo, NY 14203, USA.
Is Neurovascular Diagnostics Inc. registered in SAM.gov?
Yes. Neurovascular Diagnostics Inc.'s SAM.gov registration is active through July 27, 2027.
What is Neurovascular Diagnostics Inc.'s most recent federal award?
Neurovascular Diagnostics Inc.'s most recent federal grant award is Testing a blood-based assay for detection and risk assessment of intracranial aneurysms in familial cases - project… (R43NS145909), from National Institute of Neurological Disorders and Stroke, on September 16, 2025.
On GovTribe
See Neurovascular Diagnostics Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors